Alpharetta, GA, United States of America

Michael P Czabala


Average Co-Inventor Count = 1.4

ph-index = 6

Forward Citations = 423(Granted Patents)


Location History:

  • Roswell, GA (US) (1999 - 2002)
  • Alpharetta, GA (US) (2002)

Company Filing History:


Years Active: 1999-2002

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael P Czabala: Innovator in Oxygen Concentration Systems

Introduction

Michael P Czabala is a notable inventor based in Alpharetta, GA (US), recognized for his contributions to the field of oxygen concentration systems. With a total of seven patents to his name, Czabala has made significant advancements that cater to various oxygen capacity requirements for end users.

Latest Patents

Czabala's latest patents include a Total Delivery Oxygen Concentration System, which is designed to supply concentrated oxygen efficiently. This system features a primary oxygen concentrating device that can operate independently or in conjunction with a supplemental device. When both devices work together, the primary device provides compressed air while receiving concentrated oxygen from the supplemental device, resulting in a combined flow for the user. Another notable patent is the Compressor Muffler, which aims to reduce noise associated with compressors. This muffler assembly is integrated with the compressor and includes a baffle that disrupts the gas flow, thereby attenuating noise effectively.

Career Highlights

Throughout his career, Czabala has worked with various companies, including Respironics, Inc. His experience in the industry has allowed him to develop innovative solutions that address the needs of users requiring concentrated oxygen.

Collaborations

Czabala has collaborated with professionals in his field, including Robert W Murdoch, to enhance the development of his inventions.

Conclusion

Michael P Czabala's work in the field of oxygen concentration systems showcases his dedication to innovation and improvement in healthcare technology. His patents reflect a commitment to enhancing the quality of life for individuals requiring oxygen therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…